Nadia Naldi

2.3k total citations · 1 hit paper
43 papers, 1.6k citations indexed

About

Nadia Naldi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nadia Naldi has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nadia Naldi's work include HER2/EGFR in Cancer Research (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Breast Cancer Treatment Studies (9 papers). Nadia Naldi is often cited by papers focused on HER2/EGFR in Cancer Research (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Breast Cancer Treatment Studies (9 papers). Nadia Naldi collaborates with scholars based in Italy, United States and Germany. Nadia Naldi's co-authors include Roberta Camisa, Andrea Ardizzoni, Beatrice Bortesi, Antonino Musolino, Marzia Capelletti, Tauro Maria Neri, Debora Pezzuolo, Giancarlo Bisagni, Gabriele Missale and Alessandro Zerbini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Nadia Naldi

43 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer

2008 745 citations Antonino Musolino, Nadia Naldi et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadia Naldi Italy	19	958	600	574	389	368	43	1.6k
Beatrice Bortesi Italy	15	874 0.9×	520 0.9×	502 0.9×	337 0.9×	447 1.2×	33	1.4k
P Bertheau France	16	800 0.8×	287 0.5×	536 0.9×	173 0.4×	234 0.6×	35	1.5k
Rajiv Bassi United States	19	783 0.8×	288 0.5×	925 1.6×	232 0.6×	373 1.0×	26	1.7k
WJ Gullick United Kingdom	18	1.1k 1.2×	544 0.9×	751 1.3×	86 0.2×	269 0.7×	26	1.6k
Rafael Molina Spain	18	1.1k 1.2×	476 0.8×	557 1.0×	104 0.3×	222 0.6×	33	1.7k
Xenia Jimenez United States	22	670 0.7×	630 1.1×	1.2k 2.1×	182 0.5×	227 0.6×	27	1.7k
David Gancberg Belgium	14	1.1k 1.2×	486 0.8×	631 1.1×	94 0.2×	195 0.5×	32	1.5k
Sigitas Verselis United States	16	693 0.7×	252 0.4×	918 1.6×	344 0.9×	96 0.3×	31	1.7k
Gaia Griguolo Italy	24	1.1k 1.1×	290 0.5×	269 0.5×	164 0.4×	431 1.2×	87	1.4k
Toni M. Brand United States	19	807 0.8×	213 0.4×	720 1.3×	276 0.7×	365 1.0×	27	1.5k

Countries citing papers authored by Nadia Naldi

Since Specialization

Citations

This map shows the geographic impact of Nadia Naldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Naldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Naldi more than expected).

Fields of papers citing papers by Nadia Naldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Naldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Naldi. The network helps show where Nadia Naldi may publish in the future.

Co-authorship network of co-authors of Nadia Naldi

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Naldi. A scholar is included among the top collaborators of Nadia Naldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Naldi. Nadia Naldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boggiani, Daniela, Maria Michiara, Nadia Naldi, et al.. (2019). Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Frontiers in Oncology. 9. 759–759. 22 indexed citations

Monica, Silvia La, Daniele Cretella, Mara Bonelli, et al.. (2017). Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines. Journal of Experimental & Clinical Cancer Research. 36(1). 174–174. 67 indexed citations

Musolino, Antonino, Nadia Naldi, Maria Vittoria Dieci, et al.. (2016). Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. The Pharmacogenomics Journal. 16(5). 472–477. 20 indexed citations

Negri, Francesca, Antonino Musolino, Nadia Naldi, et al.. (2013). Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy. The Pharmacogenomics Journal. 14(1). 14–19. 17 indexed citations

Bozzetti, Cecilia, Nadia Naldi, Rita Nizzoli, et al.. (2013). Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer. Lung Cancer. 80(1). 35–38. 12 indexed citations

Tiseo, Marcello, Paola Bordi, Beatrice Bortesi, et al.. (2013). ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. British Journal of Cancer. 108(8). 1695–1703. 64 indexed citations

Bozzetti, Cecilia, Francesca Negri, Cinzia Azzoni, et al.. (2012). Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples. Diagnostic Cytopathology. 41(7). 595–598. 24 indexed citations

Musolino, Antonino, Nadia Naldi, Beatrice Bortesi, et al.. (2008). Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 26(11). 1789–1796. 745 indexed citations breakdown →

Musolino, Antonino, Maria Angela Bella, Beatrice Bortesi, et al.. (2007). BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. The Breast. 16(3). 280–292. 101 indexed citations

10.

Musolino, Antonino, Maria Michiara, Maria Angela Bella, et al.. (2005). Molecular Profile and Clinical Variables in Brca1-Positive Breast Cancers. A Population-Based Study. Tumori Journal. 91(6). 505–512. 14 indexed citations

11.

Ruzzo, Annamaria, Francesco Graziano, Francesca Pizzagalli, et al.. (2005). Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Annals of Oncology. 16(6). 887–892. 59 indexed citations

12.

Musolino, Antonino, Nadia Naldi, Maria Michiara, et al.. (2005). A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes. Breast Cancer Research and Treatment. 91(2). 203–205. 20 indexed citations

13.

Bozzetti, Cecilia, Nicola Personeni, Rita Nizzoli, et al.. (2003). HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma. Cancer. 99(5). 310–315. 36 indexed citations

14.

Nizzoli, Rita, Cecilia Bozzetti, Pellegrino Crafa, et al.. (2003). Immunocytochemical evaluation of HER‐2/neu on fine‐needle aspirates from primary breast carcinomas. Diagnostic Cytopathology. 28(3). 142–146. 27 indexed citations

15.

Bozzetti, Cecilia, Rita Nizzoli, Annamaria Guazzi, et al.. (2002). HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Annals of Oncology. 13(9). 1398–1403. 48 indexed citations

16.

Nizzoli, Rita, Nadia Naldi, Annamaria Guazzi, et al.. (2000). Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas. Cancer. 90(1). 61–66. 43 indexed citations

17.

Bozzetti, Cecilia, Vittorio Franciosi, Pellegrino Crafa, et al.. (2000). Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections. Lung Cancer. 29(1). 33–41. 18 indexed citations

18.

Bozzetti, Cecilia, Rita Nizzoli, Roberta Camisa, et al.. (1997). Comparison between ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma. Cancer. 81(5). 287–292. 15 indexed citations

19.

Bozzetti, Cecilia, Rita Nizzoli, Nadia Naldi, et al.. (1996). Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer. Diagnostic Cytopathology. 15(2). 116–120. 10 indexed citations

20.

Bozzetti, Cecilia, Roberta Camisa, Rita Nizzoli, et al.. (1995). Estrogen and progesterone receptors in human meningiomas: Biochemical and immunocytochemical evaluation. Surgical Neurology. 43(3). 230–234. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact